Ulanqab, China - September 2026 - Ulanqab Kema New Material Co., Ltd., a leading manufacturer of polyvinylpyrrolidone (PVP) and related pharmaceutical excipients, is pleased to announce its participation in CPHI Milan 2026, the world's premier pharmaceutical industry event.
The company will be showcasing its full range of high-quality pharmaceutical-grade PVP products at Booth 1D108 from October 6–8, 2026, at Fiera Milano, Italy.
Global Platform, Strategic Presence
CPHI Worldwide is the largest and most influential event in the global pharmaceutical supply chain, bringing together over 3,600 companies from more than 150 countries and regions. As one of China's most experienced manufacturers and suppliers of polyvinylpyrrolidone excipients, Ulanqab Kema New Material Co., Ltd. is proud to join this prestigious gathering to demonstrate the strength of Chinese pharmaceutical excipient manufacturing on the global stage.
Comprehensive Product Portfolio on Display
At CPHI Milan 2026, the company will feature its six core product categories:
Pharmaceutical-grade PVP K17, K30, and K90 - versatile binders, film-formers, battery, and stabilizers for solid dosage forms
Cross-linked Povidone (PVPP) - superior disintegrant for tablets and capsules
Povidone-Iodine (PVP-I) - broad-spectrum disinfectant for medical and wound care applications
High-purity NVP monomer - essential raw material for PVP production
The flagship product, pharmaceutical-grade PVP K30, stands out with its ultra-low moisture content, high purity, low heavy metals, and excellent dissolution stability - meeting the demanding requirements for oral solid dosage forms, injectables, iodophors, and biological dressings. Meanwhile, PVPP offers exceptional disintegration performance with strong water absorption and swelling capacity without gel formation, ensuring rapid drug release and optimal bioavailability.
Quality and Compliance at the Core
Ulanqab Kema New Material Co., Ltd. operates under stringent quality management systems, holding ISO 9001, ISO 14001, and ISO 45001 certifications. The company's PVPP products comply with USP/EP/CP pharmacopoeia standards, with DMF files available for US market submissions and REACH & TCSA registrations for global market access.
Located in Mengwei New Material Industrial Park, Chayouhou Banner, the company was established in 2017 with a registered capital of RMB 50 million. Its state-of-the-art production facility features an annual output of 5,000 tons of NVP and 1,500 tons of PVP series products, with continuous production processes that break conventional intermittent manufacturing.
Meet the Team in Milan
The company's professional technical and international trade team will be available throughout the exhibition for one-on-one consultations, covering production processes, quality control, regulatory compliance, customized production, and cross-border supply chain capabilities. Visitors are invited to discuss partnership opportunities in long-term raw material supply, regional distribution, and customized R&D collaboration.
Event Details
| Event | CPHI Milan 2026 (CPHI Worldwide) |
| Dates | October 6–8, 2026 |
| Venue | Fiera Milano, Rho, Italy |
| Booth | 1D108 |
We look forward to welcoming global partners, pharmaceutical manufacturers, and industry professionals at our booth. Together, let's explore new possibilities for high-quality pharmaceutical excipients and sustainable industry development.
About Ulanqab Kema New Material Co., Ltd.
Ulanqab Kema New Material Co., Ltd. is a leading Chinese manufacturer of N-vinylpyrrolidone (NVP) and polyvinylpyrrolidone (PVP) series products, including PVP K30, PVP K90, PVP K17, cross-linked povidone (PVPP), and povidone-iodine (PVP-I). With applications spanning pharmaceuticals, food processing, textiles, industrial coatings, and biomaterials, the company is committed to innovation, quality, and sustainable manufacturing. For more information, please visit www.ulkmpvp.com.